FILTER

FILTERED INTERVIEW RESULTS

Mining
DRC
MACIG

Adry Nzonzimbu

DIRECTOR, MINEQUIP
MACIG 2020 DRC Pre-Release Edition
Minequip prepares to transform its operations in the DRC with the opening of a new warehouse and repair facility this year.
Mining
DRC
MACIG

Deon Heyns

CEO, CONGO EQUIPMENT
MACIG 2020 DRC Pre-Release Edition
Congo Equipment is the official CAT dealer for the mining region of DRC.
Mining
DRC
MACIG

Louison Kiyombo

PARTNER, KPMG
MACIG 2020 DRC Pre-Release Edition
KPMG draws on global experience and local expertise to help clients navigate the DRC’s complicated legislative framework.
Mining
DRC
MACIG

Cécile Amory

GENERAL MANAGER, MINING CONTRACTING SERVICES CONGO (MCSC)
MACIG 2020 DRC Pre-Release Edition
Local contracting firm MCSC discusses its strategy for ensuring sustainable growth in the risky DRC mining game.
Mining
DRC
MACIG

Rodolphe Kembukuswa

GENERAL MANAGER, BOLLORÉ LOGISTICS DRC
Bolloré DRC believes it has a key role to play in streamlining cargo flows and securing supply and exit corridors for the country.
Mining
DRC
MACIG

Malta Forrest

EXECUTIVE VICE PRESIDENT & CEO, GROUPE FORREST
MACIG 2020 DRC Pre-Release Edition
Groupe Forrest is a completely family-owned company that has been operating in the DRC since 1922 without interruption.
Mining
DRC
MACIG

Nigel Ferguson

MANAGING DIRECTOR, AVZ MINERALS LIMITED
AVZ Minerals moves forward with its mega-lithium project in the DRC.
Mining
DRC
MACIG

Miles Naude

GENERAL MANAGER, MMG
MMG is nearing completion of a feasibility study for the expansion of its Kinsevere mine in the DRC.
Mining
DRC
MACIG

Mark Bristow

CEO, BARRICK GOLD CORPORATION
The Barrick Gold merger resulted in the world’s largest gold company – what’s next for its African assets?
Mining
Ghana
MACIG

Liam Morrissey

CEO, MS RISK
MS Risk identifies, mitigates and reduces security risk to protect client assets around the world and across several sectors.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL